评估经阴道超声胎盘植入谱系评分系统以判断胎盘植入谱系严重程度
本研究在独立队列中评估经阴道超声胎盘植入谱系(PAS)评分系统的性能及其与失血量和手术复杂度的关联。回顾性纳入2023至2024年转诊至四级中心的连续疑似PAS患者78例,按评分分为4类。结果显示评分类别越高,计算估计失血量、膀胱切开、ICU入住及保守管理等手术复杂度指标越显著增加,提示该评分可能识别重症病例。
要点
- 经阴道超声PAS评分将患者分为4类,类别越高计算估计失血量越大(类别0中位738 mL vs 类别3中位1353 mL,P<.001)。
- 类别3患者膀胱切开率27.2%,ICU入住率86.3%,均显著高于其他类别(P<.001)。
- 类别2和3的剖宫产子宫切除术率各为40%,高于类别1的18%和类别0的0%(P<.0001)。
核心结论
- 本研究在独立队列中证实经阴道超声PAS评分的性能及其与计算估计失血量和手术复杂度的关联;类别3病例失血量最高、手术复杂度最大,提示该评分可能识别重症病例。
研究设计与样本
- 回顾性队列研究,纳入2023至2024年转诊至四级中心的连续疑似PAS患者86例,最终分析78例。
- 由对病史和临床结局设盲的检查者回顾性评分图像和视频,按子宫壁缺损、动脉血管分布和宫颈受累3个域各评0至3分,累积0至9分转换为4类。
- 患者按常规临床方案管理,不基于经阴道超声PAS评分,包括剖宫产取胎盘、剖宫产子宫切除术和保守管理(伴或不伴延迟子宫切除术)。
主要发现
- 评分类别分布:类别0为20例(25.6%),类别1为11例(14.1%),类别2为25例(32%),类别3为22例(28.2%)。
- 计算估计失血量中位数(四分位距):类别0为738(604-926)mL,类别1为1167(949-1677)mL,类别2为1166(732-1871)mL,类别3为1353(1028-2250)mL(P<.001);类别3与其他类别相比失血量更大(β=1.35,P=.002)。
- 膀胱切开仅见于类别3患者(27.2%);ICU入住率类别3最高(86.3%),类别0、1、2分别为5%、18.1%、60%(P<.001)。
- 剖宫产子宫切除术在类别2和3各为40%,高于类别1的18%和类别0的0%(P<.0001);保守管理(伴或不伴延迟子宫切除术)在类别3最常见(54.5%),约为类别2(24%)的两倍,类别0和1无患者接受保守管理(P<.001)。
临床怎么用
- 作者认为经阴道超声PAS评分可能识别重症病例;这些趋势提示较高的经阴道超声PAS类别与更广泛的手术干预一致,但管理仍受多种因素影响。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We previously developed the transvaginal ultrasound in placenta accreta spectrum scoring system to stratify severity of suspected placenta accreta spectrum cases. By evaluating the loss of uterine wall interface in the lower uterine segment, arterial vascularity, and cervical involvement, we established a framework to categorize placenta accreta spectrum severity based on its association with intraoperative blood loss. OBJECTIVE: This study evaluates the performance of transvaginal ultrasound in placenta accreta spectrum scoring in an independent cohort and assesses its association with blood loss and surgical complexity, such as cystotomy. STUDY DESIGN: We studied a retrospective cohort of consecutive patients referred to a quaternary center for suspected placenta accreta spectrum from 2023 to 2024. The lower uterine segment and cervix were evaluated by transvaginal ultrasound per predefined protocol, evaluating the utero-placental interface and cervical involvement with bladder half-full. Patients were managed per usual clinical approach, not based on transvaginal ultrasound in placenta accreta spectrum scoring, including cesarean section with placenta removal, cesarean hysterectomy, and conservative management with or without delayed hysterectomy. An examiner blinded to patient history and clinical outcomes retrospectively scored images and clips. Patients were assigned scores of 0 to 3 in 3 domains: uterine wall defect, arterial vascularity, and cervical involvement. Cumulative scores of 0 to 9 were converted into 4 categories, as previously published: Category 0: placenta accreta spectrum score 0; Category 1: placenta accreta spectrum score 1 to 3; Category 2: placenta accreta spectrum score 4 to 6; and Category 3: placenta accreta spectrum score 7 to 9. The primary outcome was calculated estimated blood loss during the primary surgery. Secondary outcomes were blood product transfusion, intensive care unit admission, length of hospital stay, and bladder injury. RESULTS: Of 86 patients referred, 78 were included in the analysis. Transvaginal ultrasound in placenta accreta spectrum scores were distributed as follows: 20 patients (25.6%) were classified as Category 0, 11 (14.1%) as Category 1, 25 (32%) as Category 2, and 22 (28.2%) as Category 3. The primary outcome, calculated estimated blood loss, differed significantly by transvaginal ultrasound in placenta accreta spectrum scoring category: median (interquartile range) calculated estimated blood loss was 738 (604-926) mL in Category 0, 1167 (949-1677) mL in Category 1, 1166 (732-1871) mL in Category 2, and 1353 (1028-2250) mL in Category 3 (P<.001). Category 3 was independently associated with greater blood loss than other categories (β=1.35, P=.002). Cystotomy was exclusively performed in Category 3 patients (27.2%). Additionally, Category 3 had the highest rate of intensive care unit admission (86.3%), with 5%, 18.1%, and 60% in Categories 0, 1, and 2, respectively (P<.001). Surgical management differed across transvaginal ultrasound in placenta accreta spectrum categories. Cesarean hysterectomy was more common in Categories 2 and 3 (40% each) than Categories 1 (18%) and 0 (0%) (P<.0001). Conservative management with or without delayed hysterectomy was most frequent in Category 3 (54.5%), at nearly twice the rate as in Category 2 (24%); no patients in Categories 0 and 1 underwent conservative management (P<.001). These trends suggest that higher transvaginal ultrasound in placenta accreta spectrum categories align with more extensive surgical interventions, although management remains multifactorial. CONCLUSION: Our study evaluated transvaginal ultrasound in placenta accreta spectrum scoring in an independent cohort and confirmed its performance and its association with estimated blood loss and surgical complexity in placenta accreta spectrum. Category 3 cases were associated with the highest blood loss and surgical complexity, indicating that transvaginal ultrasound in placenta accreta spectrum scoring may be able to identify severe cases.
引用
- Agarwal N, Amro FH, Mehl SB, et al. Evaluating transvaginal ultrasound in placenta accreta spectrum scoring to determine placenta accreta spectrum severity. Am J Obstet Gynecol. 2025. PMID: 41232789. doi:10.1016/j.ajog.2025.11.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。